Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-7-9

Curated date: 2025/07/05

Curator: Ese

Revision editor(s): Ese

Subjects

Location of subjects
China
Finland
Germany
Italy
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Parkinson's disease IDIOPATHIC PARKINSON DIS,Idiopathic Parkinson Disease,Idiopathic Parkinson's Disease,IDIOPATHIC PARKINSONS DIS,Idiopathic PD,LEWY BODY PARKINSON DIS,Lewy Body Parkinson Disease,Lewy Body Parkinson's Disease,Paralysis agitans,paralysis agitans,PARKINSON DIS,PARKINSON DIS IDIOPATHIC,Parkinson disease,Parkinson Disease, Idiopathic,Parkinson syndrome,Parkinson's,Parkinson's disease,Parkinson's disease (disorder),Parkinson's disease NOS,Parkinson's disease NOS (disorder),Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinson's syndrome,Parkinsonian disorder,Parkinsonism, Primary,Parkinsons,PARKINSONS DIS,PARKINSONS DIS IDIOPATHIC,PARKINSONS DIS LEWY BODY,Parkinsons disease,Primary Parkinsonism,parkinson's disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control
Group 1 name Corresponds to the case (exposed) group for case-control studies
Parkinson's Disease (PD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants were classified as Parkinson's Disease (PD) patients after the use of UK Brain Bank criteria for the diagnosis of Parkinson's Disease (PD)
Group 0 sample size Number of subjects in the control (unexposed) group
751
Group 1 sample size Number of subjects in the case (exposed) group
1092

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
centered log-ratio
Statistical test
ANCOM-BC
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-7-9

Curated date: 2025/07/05

Curator: Ese

Revision editor(s): Ese, Victoria

Source: Table SE1

Description: Differentially abundant bacterial taxa identified in a sub group meta analysis with confounders controlled for age and sex

Abundance in Group 1: increased abundance in Parkinson's Disease (PD) patients

NCBI Quality ControlLinks
Acidaminobacter
Akkermansia
Anaerotruncus
Bifidobacteriaceae
Bifidobacterium
Desulfurispora
Eisenbergiella
Eubacteriales Family XII. Incertae Sedis
Lactobacillaceae
Lactobacillus
Porphyromonadaceae
Porphyromonas
Synergistaceae
Verrucomicrobiaceae
Peptococcaceae 2Peptococcaceae 2
Verrucomicrobiota
Synergistota

Revision editor(s): Ese, Victoria

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-7-9

Curated date: 2025/07/06

Curator: Ese

Revision editor(s): Ese

Source: Table SE1

Description: Differentially abundant bacterial taxa identified in a sub group meta analysis with confounders controlled for age and sex

Abundance in Group 1: decreased abundance in Parkinson's Disease (PD) patients

NCBI Quality ControlLinks
Blautia
Butyricicoccus
Enterobacteriaceae
Faecalibacterium
Fusicatenibacter
Lachnospiraceae
Prevotella
Pseudomonadota
Roseburia

Revision editor(s): Ese